Cardio Clinical Digest · Mar 19 Daily Digest
Heart Failure Developments
- 🔥 Shingles Vaccine Benefits: Heart disease patients who received the shingles vaccine had nearly half the rate of...

Created by Jesse Linson
Latest cardiology research, guideline updates, and evidence‑based prevention tips
Explore the latest content tracked by Cardio Clinical Digest
Key insights from celery juice analysis for heart health:
New ACSM guidelines after 17 years prioritize consistency over perfection, ignoring weight or body comp bias.
Key positives for CV health:
Challenging old advice—AFib patients traditionally told to avoid caffeine—but evidence shows daily coffee reduces risk.
Key findings from DECaf RCT...
Prioritize waist measurements in prevention clinics: they're a low-cost tool for early heart failure risk detection.
Key findings:
Simple prevention win: Shingles vaccine cuts heart attack, stroke, or cardiac emergencies by 46% in heart disease patients—comparable to quitting...
Japan approves stem cell therapies for heart failure and Parkinson's, signaling emerging regenerative options in cardiovascular management amid global regulatory advances.
Key disparities in US heart failure (HF) care:
Hunt for an equity paradigm is urgent to address these gaps.
Emerging nutraceutical for BP prevention: A meta-analysis of 10 RCTs (349 participants) found NMN (250-1,500mg/day, 4-12 weeks) linked to 2.15 mmHg...
New early clinical data shows AI analyzing data from widely available consumer wearables to deliver actionable insights for heart failure monitoring. This could transform everyday heart health management.
Emerging trends highlight simple interventions as complements to standard CV strategies:
Hypertensive individuals improving from low to high healthy lifestyle scores slashed heart disease and diabetes risk by 12–44%. Game-changing evidence to prioritize lifestyle in hypertension management.
The new cholesterol guidelines recommend apoB, lipoprotein(a), and coronary artery calcium testing to identify hidden cardiovascular risk—enabling earlier prevention.
Innovative stem cell therapy now approved for severe heart failure, signaling a step toward transformative regenerative medicine through innovative options and safer, more accessible global stem cell therapies.
Key updates from the new ACC/AHA dyslipidemia guidelines emphasize earlier action for primary prevention:
Practical CVD prevention boost from COSMOS trial in 21,000+ older adults:
Key changes emphasize earlier intervention for ASCVD prevention: